{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:16:56Z","timestamp":1786987016330,"version":"build-2736575974"},"reference-count":191,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.clinre.2011.10.007","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T00:09:09Z","timestamp":1328227749000},"page":"420-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["PSC, AIH and overlap syndrome in inflammatory bowel disease"],"prefix":"10.1016","volume":"36","author":[{"given":"P.J.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2011.10.007_bib0005","first-page":"87","article-title":"Ulceration of the colon with a much enlarged fatty liver","volume":"4","author":"Thomas","year":"1873","journal-title":"Trans Pathol Soc Phil"},{"key":"10.1016\/j.clinre.2011.10.007_bib0010","first-page":"130","article-title":"A specimen of diffuse ulcerative colitis with secondary diffuse hepatitis","volume":"50","author":"Lister","year":"1899","journal-title":"Trans Pathol Soc Lon"},{"key":"10.1016\/j.clinre.2011.10.007_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.510300101","article-title":"Primary sclerosing cholangitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0025","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/oxfordjournals.qjmed.a067266","article-title":"The liver in ulcerative colitis","volume":"40","author":"Perrett","year":"1971","journal-title":"Q J Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0055","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/00365528009181516","article-title":"Sclerosing cholangitis in ulcerative colitis","volume":"15","author":"Schrumpf","year":"1980","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinre.2011.10.007_bib0065","first-page":"227","article-title":"Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease","volume":"50","author":"Okada","year":"1996","journal-title":"Acta Med Okayama"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hepres.2004.03.006","article-title":"Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients","volume":"29","author":"Takikawa","year":"2004","journal-title":"Hepatol Res"},{"issue":"Suppl.","key":"10.1016\/j.clinre.2011.10.007_bib0075","doi-asserted-by":"crossref","first-page":"s510","DOI":"10.1016\/S0168-8278(11)61296-8","article-title":"PSC-Crohns disease: characterisation of this patient group for the first time reveals a unique clinical phenotype","volume":"4","author":"Halliday","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0100","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/hep.24307","article-title":"Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9","volume":"53","author":"Janse","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0105","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-933560","article-title":"Primary sclerosing cholangitis: epidemiology, natural history, and prognosis","volume":"26","author":"Levy","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.10.007_bib0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00042737-199706000-00005","article-title":"Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques","volume":"9","author":"Bansi","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0130","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","author":"Xu","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0140","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2007.01.039","article-title":"Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis","volume":"132","author":"Karrar","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O\u2019Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2011.10.007_bib0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0160","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0168-8278(06)80020-6","article-title":"Liver dendritic cells in primary sclerosing cholangitis (PSC) are unable to imprint mucosal adhesion molecules in primed lymphocytes without exogenous retinoic acid","volume":"44","author":"Eksteen","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0165","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0170","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7861\/clinmedicine.4-2-173","article-title":"Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease","volume":"4","author":"Eksteen","year":"2004","journal-title":"Clin Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.10.007_bib0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.007_bib0190","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.24085","article-title":"Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity","volume":"53","author":"Liaskou","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0195","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/gast.1996.v110.pm8613056","article-title":"Risk of primary sclerosing cholangitis is associated with non-smoking behavior","volume":"110","author":"van Erpecum","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0200","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0205","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1053\/gast.1996.v110.agast961658","article-title":"Protection from primary sclerosing cholangitis: smoke trails of just coattails?","volume":"110","author":"Cohen","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","article-title":"BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Pauli-Magnus","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0168-8278(02)00161-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis","volume":"37","author":"Girodon","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0225","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1572-0241.2005.41072.x","article-title":"Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis","volume":"100","author":"Gallegos-Orozco","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","article-title":"Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis","volume":"113","author":"Sheth","year":"2003","journal-title":"Hum Genet"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.clinre.2011.10.007_bib0235","first-page":"A41","article-title":"Prevalence and determinants of primary sclerosing cholangitis in a cohort of patients with inflammatory bowel disease and normal liver function tests","volume":"57","author":"Bungay","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC\u2013IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02234825","article-title":"Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study","volume":"44","author":"Lindberg","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2011.10.007_bib0250","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/jhep.2002.32931","article-title":"Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways","volume":"35","author":"Guicciardi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0260","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1590-8658(03)00076-8","article-title":"Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey","volume":"35","author":"Okolicsanyi","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2011.10.007_bib0270","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","article-title":"Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study","volume":"14","author":"O\u2019Brien","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0275","first-page":"1472","article-title":"Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period","volume":"43","author":"De Maria","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0280","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis: Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0285","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(98)80059-7","article-title":"Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single vs. multiple daily doses","volume":"29","author":"van Hoogstraten","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0290","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1872-034X.2009.00527.x","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials","volume":"39","author":"Shi","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2011.10.007_bib0295","first-page":"CD003626","article-title":"Bile acids for primary sclerosing cholangitis","volume":"2","author":"Chen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinre.2011.10.007_bib0300","first-page":"CD003626","article-title":"Bile acids for primary sclerosing cholangitis","volume":"1","author":"Poropat","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinre.2011.10.007_bib0305","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0310","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","article-title":"Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period","volume":"20","author":"Stiehl","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0320","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0325","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0330","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.510260102","article-title":"Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver","volume":"26","author":"Benedetti","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0340","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.clinre.2011.10.007_bib0345","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2036.2011.04822.x","article-title":"ursodeoxycholic acid forprimary sclerosing cholangitis","volume":"34","author":"Triantos","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.10.007_bib0350","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0355","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0360","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","article-title":"Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study","volume":"26","author":"Stiehl","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0370","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2036.2005.02407.x","article-title":"Review of the current management of primary sclerosing cholangitis","volume":"21","author":"Cullen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.10.007_bib0375","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.transproceed.2003.09.017","article-title":"Liver transplantation for primary sclerosing cholangitis","volume":"35","author":"Solano","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinre.2011.10.007_bib0380","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1572-0241.2004.04050.x","article-title":"Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC","volume":"99","author":"Maheshwari","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0385","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0039-6060(05)80078-9","article-title":"Primary sclerosing cholangitis: liver transplantation or biliary surgery","volume":"117","author":"Farges","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.clinre.2011.10.007_bib0390","doi-asserted-by":"crossref","unstructured":"Ngu JH, Gearry RB, Wright AJ, Stedman CA. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2011 Sep 2 [Epub ahead of print].","DOI":"10.1016\/j.cgh.2011.08.027"},{"issue":"10","key":"10.1016\/j.clinre.2011.10.007_bib0395","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.007_bib0400","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2010.02.030","article-title":"In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival","volume":"53","author":"Rudolph","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0405","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a metaanalysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0415","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1572-0241.2007.01070.x","article-title":"Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota","volume":"102","author":"Jess","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.clinre.2011.10.007_bib0420","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0425","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(87)90766-5","article-title":"Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis","volume":"2","author":"Hill","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.10.007_bib0430","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0016-5085(93)90846-5","article-title":"Increased serum deoxycholic acid levels in men with colorectal adenomas","volume":"104","author":"Bayerdorffer","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0435","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3835(88)90023-7","article-title":"Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer","volume":"38","author":"Stadler","year":"1988","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinre.2011.10.007_bib0440","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","article-title":"Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production","volume":"4","author":"Rodrigues","year":"1998","journal-title":"Mol Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0445","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.0.CO;2-O","article-title":"Colonic mucosal proliferation is related to serum deoxycholic acid levels","volume":"85","author":"Ochsenkuhn","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2011.10.007_bib0450","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/gast.2001.22434","article-title":"Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis","volume":"120","author":"Heuschen","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0455","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/01635589809514689","article-title":"Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation","volume":"31","author":"Martinez","year":"1998","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clinre.2011.10.007_bib0460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0465","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.clinre.2011.10.007_bib0470","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.10.007_bib0475","doi-asserted-by":"crossref","unstructured":"Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol 2011;106(9):1638\u201345.","DOI":"10.1038\/ajg.2011.156"},{"key":"10.1016\/j.clinre.2011.10.007_bib0480","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0485","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0490","first-page":"252","article-title":"Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis","volume":"38","author":"Villamil","year":"2008","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0495","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation\u2013a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0500","doi-asserted-by":"crossref","unstructured":"Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis. Inflamm Bowel Dis 2011 doi:10.1002\/ibd.21692 [Epub ahead of print].","DOI":"10.1002\/ibd.21692"},{"key":"10.1016\/j.clinre.2011.10.007_bib0505","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0016-5085(99)70279-9","article-title":"Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps","volume":"117","author":"Rubin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0510","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0016-5085(99)70278-7","article-title":"Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis","volume":"117","author":"Engelsgjerd","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0515","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0016-5085(81)90727-7","article-title":"Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy","volume":"80","author":"Blackstone","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0520","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(94)90813-3","article-title":"Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?","volume":"343","author":"Bernstein","year":"1994","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0525","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10350-004-6655-5","article-title":"Atrophy and neoplastic transformation of the ileal pouch in patients with UC and PSC: a case control study","volume":"46","author":"Stahlberg","year":"2003","journal-title":"Dis Colon Rectum"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.clinre.2011.10.007_bib0530","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2036.2006.03065.x","article-title":"Review article: colon-saving medical therapy vs. colectomy in ulcerative colitis-the case for colectomy","volume":"24","author":"Oresland","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0535","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10350-006-0517-2","article-title":"Adenocarcinoma in an ileoanal pouch formed for ulcerative colitis in a patient with primary sclerosing cholangitis and a liver transplant: report of a case and review of the literature","volume":"49","author":"Walker","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2011.10.007_bib0540","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10350-008-9250-3","article-title":"Laparoscopic ileal pouch-anal anastomosis in patients with chronic ulcerative colitis and primary sclerosing cholangitis: a case-matched study","volume":"51","author":"Benavente-Chenhalls","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2011.10.007_bib0545","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0550","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s10350-007-0278-6","article-title":"Longterm outcome after ileal pouch-anal anastomosis: function and health-related quality of life","volume":"50","author":"Berndtsson","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2011.10.007_bib0555","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1463-1318.2004.00716.x","article-title":"The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term follow-up study","volume":"6","author":"Borjesson","year":"2004","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0560","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10350-004-6194-0","article-title":"Adenocarcinoma below ileoanal anastomosis for ulcerative colitis: report of a case and review of the literature","volume":"45","author":"Laureti","year":"2002","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0565","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ibd.20278","article-title":"Outcome after proctocolectomy with an ileal pouch-anal anastomosis for ulcerative colitis","volume":"14","author":"Ferrante","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0570","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00000658-199304000-00002","article-title":"Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis","volume":"217","author":"Kartheuser","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinre.2011.10.007_bib0575","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0580","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00365529850170883","article-title":"Chronic inflammatory changes in the pouch mucosa are associated with cholangitis found on peroperative liver biopsy specimens at restorative proctocolectomy for ulcerative colitis","volume":"33","author":"Aitola","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0585","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.surg.2005.07.014","article-title":"Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case control study","volume":"138","author":"Gorgun","year":"2005","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0590","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ibd.20384","article-title":"Prevalence of primary sclerosing cholangitis in ulceratice colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis","volume":"14","author":"Lepisto","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.clinre.2011.10.007_bib0595","first-page":"2177","article-title":"Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis","volume":"90","author":"Zins","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0600","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cgh.2007.09.018","article-title":"Impact of orthotopic liver transplant for PSC on chronic antibiotic refractory pouchitis","volume":"6","author":"Freeman","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2011.10.007_bib0605","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bjs.6210","article-title":"Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis","volume":"95","author":"Mathis","year":"2008","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.clinre.2011.10.007_bib0610","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0025-6196(11)64839-8","article-title":"Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy","volume":"71","author":"Kartheuser","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinre.2011.10.007_bib0615","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favorable long-term prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.10.007_bib0620","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broom\u00e9","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0625","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: prevalence and natural history","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0630","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0635","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study autoimmune hepatitis\u2014a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0640","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0645","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0650","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0655","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"23","key":"10.1016\/j.clinre.2011.10.007_bib0660","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.3748\/wjg.v12.i23.3628","article-title":"Genetics of inflammatory bowel disease: the role of the HLA complex","volume":"12","author":"Ahmad","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0665","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0140-6736(90)93306-A","article-title":"T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis","volume":"336","author":"Wen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.10.007_bib0670","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1566524013363672","article-title":"Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity","volume":"1","author":"Wen","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0675","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specificCD8T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0680","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0685","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2011.10.007_bib0690","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0695","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2011.10.007_bib0700","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0705","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.10.007_bib0710","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1089-3261(02)00022-3","article-title":"The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants","volume":"6","author":"Carpenter","year":"2002","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0715","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0029-1233534","article-title":"Treatment of autoimmune hepatitis","volume":"29","author":"Strassburg","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.clinre.2011.10.007_bib0720","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.007_bib0725","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10620-010-1476-y","article-title":"Autoimmune hepatitis, cirrhosis, and hepatocellular carcinoma (HCC)","volume":"56","author":"Trivedi","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.007_bib0730","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","article-title":"Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series","volume":"56","author":"Wong","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2011.10.007_bib0735","first-page":"29","article-title":"Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases","volume":"35","author":"Seibold","year":"1997","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0740","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejim.2005.01.014","article-title":"Autoimmune hepatitis associated with the antiphospholipid syndrome and ulcerative colitis","volume":"16","author":"Linares","year":"2005","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0745","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00004836-200608000-00019","article-title":"Autoimmune hepatitis in association with lymphocytic colitis","volume":"40","author":"Cronin","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"2\u20133","key":"10.1016\/j.clinre.2011.10.007_bib0750","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0755","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.10.007_bib0760","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0765","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.1840360615","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0770","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0775","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0780","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","article-title":"Primary sclerosing cholangitis in childhood","volume":"92","author":"El-Shabrawi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0785","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0790","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0795","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0800","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.007_bib0805","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0810","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0815","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinre.2011.10.007_bib0820","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0825","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"L\u00fcth","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0830","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/17474124.1.2.329","article-title":"Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases","volume":"1","author":"Silveira","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0835","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","article-title":"Autoimmune cholangitis within the spectrum of autoimmune liver disease","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0840","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2011.10.007_bib0845","first-page":"900","article-title":"Two cases of inflammatory bowel disease diagnosed in the course of primary biliary cirrhosis","volume":"107","author":"Arai","year":"2010","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.clinre.2011.10.007_bib0850","doi-asserted-by":"crossref","unstructured":"Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, et al. Fine phenotypic and functional characterization of effector CD8(+) T cells in patients with primary biliary cirrhosis. Hepatology 2011 Jul 6; doi:10.1002\/hep.24526 [Epub ahead of print].","DOI":"10.1002\/hep.24526"},{"issue":"5","key":"10.1016\/j.clinre.2011.10.007_bib0855","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.007_bib0860","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.10.007_bib0865","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0870","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/jhep.2001.27543","article-title":"Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles","volume":"34","author":"Wiencke","year":"2001","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.clinre.2011.10.007_bib0875","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.3748\/wjg.14.3360","article-title":"Autoimmune paediatric liver disease","volume":"14","author":"Mieli-Vergani","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0880","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e3283388f5b","article-title":"Unique features of primary sclerosing cholangitis in children","volume":"26","author":"Mieli-Vergani","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0885","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen KK, Grzyb K, Lundin KE, Clausen OP, Aamodt G, Schrumpf E, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis 2011 Mar 31; doi:10.1002\/ibd.21699 [Epub ahead of print].","DOI":"10.1002\/ibd.21699"},{"issue":"4","key":"10.1016\/j.clinre.2011.10.007_bib0890","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen","year":"2010","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.clinre.2011.10.007_bib0895","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/DCR.0b013e3181dcb3f2","article-title":"A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis","volume":"53","author":"White","year":"2010","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.clinre.2011.10.007_bib0900","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/01.pas.0000176435.19197.88","article-title":"Pathologic features and clinical significance of \u201cbackwash\u201d ileitis in ulcerative colitis","volume":"29","author":"Haskell","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0905","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-933562","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.clinre.2011.10.007_bib0910","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2011.10.007_bib0915","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis: predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0920","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MEG.0b013e3281108068","article-title":"The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid","volume":"19","author":"Rudolph","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0925","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia dysplasia-carcinoma sequence","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0930","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.007_bib0935","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"AASLD practice guideline. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"991","key":"10.1016\/j.clinre.2011.10.007_bib0940","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/pgmj.2007.064592","article-title":"Chemoprevention and screening in primary sclerosing cholangitis","volume":"84","author":"Kitiyakara","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clinre.2011.10.007_bib0945","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.10.007_bib0950","series-title":"Autoimmune hepatitis. In: Sleisenger and Fordtran's gastrointestinal and liver disease","author":"Czaja","year":"1998"},{"key":"10.1016\/j.clinre.2011.10.007_bib0955","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111003469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111003469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:26Z","timestamp":1761894926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740111003469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":191,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S2210740111003469"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2011.10.007","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PSC, AIH and overlap syndrome in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2011.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}